{"gene":"DPH1","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":2014,"finding":"Yeast Dph1 and Dph2 form a heterodimeric complex (Dph1-Dph2) that is equivalent to the archaeal PhDph2 homodimer and is sufficient to catalyze the first step of diphthamide biosynthesis in vitro — the transfer of the 3-amino-3-carboxypropyl (ACP) group from SAM to the histidine residue of EF2, forming a C-C bond. Dph3 (KTI11), a CSL-type zinc finger protein that binds iron, serves as an electron donor in its reduced state to reduce the Fe-S cluster in Dph1-Dph2.","method":"In vitro reconstitution, EPR spectroscopy","journal":"Journal of the American Chemical Society","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with biochemical and spectroscopic validation","pmids":["24422557"],"is_preprint":false},{"year":2019,"finding":"The Dph1-Dph2 heterodimer functions asymmetrically: the [4Fe-4S] cluster-binding cysteine residues in each subunit are required for diphthamide biosynthesis in vivo, with the Dph1 cluster serving a catalytic (radical SAM) role while the Dph2 cluster facilitates reduction of the Dph1 cluster by the physiological electron donor system Dph3/Cbr1/NADH.","method":"In vitro reconstitution with site-directed mutagenesis of Fe-S cluster cysteine residues, EPR spectroscopy, in vivo complementation assays","journal":"Journal of biological inorganic chemistry","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis combined with in vitro reconstitution and EPR, defining asymmetric roles of each subunit","pmids":["31463593"],"is_preprint":false},{"year":2021,"finding":"Dph3 donates one iron atom to convert an air-degraded [3Fe-4S] cluster in Dph1-Dph2 into a functional [4Fe-4S] cluster, enabling aerobic diphthamide biosynthesis in vivo.","method":"In vitro reconstitution, EPR spectroscopy, biochemical iron quantification","journal":"Journal of the American Chemical Society","confidence":"High","confidence_rationale":"Tier 1 — direct biochemical reconstitution showing iron transfer, spectroscopically validated","pmids":["34154323"],"is_preprint":false},{"year":2005,"finding":"DPH1/OVCA1 is a component of the diphthamide biosynthetic pathway in mammalian cells; disruption of the Ovca1 gene by gene trap mutagenesis in CHO cells confers resistance to diphtheria toxin and Pseudomonas exotoxin A, demonstrating that DPH1 is required for diphthamide modification of EF-2.","method":"Gene trap mutagenesis, diphtheria toxin resistance assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — clean loss-of-function with defined molecular phenotype (diphthamide loss), replicated by later studies","pmids":["15637051"],"is_preprint":false},{"year":2004,"finding":"Loss of Ovca1 (DPH1) in mice causes cell-autonomous proliferation defects in MEFs; p53 deficiency rescues these proliferation defects and partially rescues embryonic phenotypes, placing Ovca1 genetically upstream of or in a parallel pathway to p53 for cell cycle progression.","method":"Mouse knockout, MEF proliferation assays, genetic epistasis (double mutant Ovca1;p53)","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — epistasis with p53 via double-mutant rescue, multiple phenotypic readouts in vivo","pmids":["14744934"],"is_preprint":false},{"year":1999,"finding":"Overexpression of OVCA1 in ovarian cancer A2780 cells causes a 50-60% reduction in colony formation, reduced proliferation, G1 cell cycle arrest, decreased cyclin D1 levels due to accelerated degradation, and overexpression of cyclin D1 overrides OVCA1-mediated growth suppression.","method":"Stable transfection, colony formation assay, cell cycle FACS, cyclin D1 overexpression rescue","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 — loss/gain of function with defined cell cycle phenotype and cyclin D1 rescue, single lab","pmids":["10519411"],"is_preprint":false},{"year":2000,"finding":"OVCA1 physically interacts with RBM8A and RBM8B (RNA-binding motif proteins), identified by yeast two-hybrid screening.","method":"Yeast two-hybrid","journal":"Genomics","confidence":"Low","confidence_rationale":"Tier 3 — single yeast two-hybrid interaction, no orthogonal validation","pmids":["11013075"],"is_preprint":false},{"year":2014,"finding":"OVCA1/DPH1-dependent diphthamide biosynthesis is required specifically in neural crest cells for craniofacial development (cleft palate, shortened mandible phenotypes); conditional ablation of Ovca1 in neural crest cells but not cranial paraxial mesoderm reproduces these defects, and Ovca1-null mice are resistant to diphtheria toxin subunit A-mediated neural crest cell ablation, confirming the link between DPH1 function and diphthamide on EF-2.","method":"Conditional knockout (Cre-lox in neural crest vs. mesoderm), diphtheria toxin subunit A resistance assay, transgenic rescue","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific conditional KO with defined craniofacial phenotype and molecular rescue, multiple orthogonal approaches","pmids":["24895408"],"is_preprint":false},{"year":2013,"finding":"Methylation of the CpG island in the DPH1 promoter causes transcriptional silencing of DPH1, resulting in low DPH1 RNA/protein, failure to produce diphthamide on EF-2, and resistance to the anti-CD22 immunotoxin HA22 (moxetumomab pasudotox) in the ALL cell line KOPN-8; 5-azacytidine prevents methylation and restores sensitivity.","method":"Bisulfite sequencing/methylation analysis, RT-PCR, Western blot, immunotoxin resistance assay, 5-azacytidine treatment","journal":"Leukemia research","confidence":"Medium","confidence_rationale":"Tier 2 — epigenetic writer identified (methylation), functional consequence on DPH1 expression and immunotoxin sensitivity demonstrated in cell line","pmids":["24070652"],"is_preprint":false},{"year":2017,"finding":"Functional assays in DPH1-knockout cells demonstrated that the N-terminal region and C-terminal region of DPH1 are both required for diphthamide synthesis: N-terminal truncations (L96fs*) and splice isoforms lacking 80 or 140 N-terminal amino acids are inactive, while the frameshift variant R312fs* (lacking most of the C-terminus) retains residual activity; specific missense variants S221P reduce activity while R27W and S56F retain full activity.","method":"Complementation assay in DPH1-knockout cells, diphtheria toxin ADP-ribosylation assay","journal":"Toxins","confidence":"Medium","confidence_rationale":"Tier 2 — systematic mutagenesis with functional diphthamide readout in KO cells, single lab","pmids":["28245596"],"is_preprint":false},{"year":2019,"finding":"Functional analysis of seven DPH1 missense variants from DPH1 syndrome patients using a diphtheria toxin ADP-ribosylation assay showed that five variants [p.(Leu234Pro), p.(Ala411Argfs*91), p.(Leu164Pro), p.(Leu125Pro), p.(Tyr112Cys)] compromise DPH1 function; homology modeling of the human DPH1-DPH2 heterodimer showed that loss of activity correlates with reduced opening and size of the catalytic site.","method":"Diphtheria toxin ADP-ribosylation assay, homology modeling, molecular dynamics simulations","journal":"European journal of human genetics","confidence":"Medium","confidence_rationale":"Tier 1-2 — in vitro functional assay combined with structural modeling, multiple variants tested","pmids":["30877278"],"is_preprint":false},{"year":2023,"finding":"Site-directed mutagenesis of a predicted SAM-binding pocket in Dph1 (near the FeS cluster domain, conserved in eukaryotic Dph1 but not Dph2) abolishes diphthamide synthesis in vivo, identifying specific residues near the methionine moiety of SAM as essential for SAM cleavage and ACP radical formation by the Dph1•Dph2 radical SAM enzyme.","method":"Site-directed mutagenesis, in vivo diphthamide assay, structural modeling","journal":"Biomolecules","confidence":"Medium","confidence_rationale":"Tier 1-2 — mutagenesis of active site residues with in vivo functional diphthamide readout","pmids":["38002337"],"is_preprint":false},{"year":2024,"finding":"Tandem cysteine motifs (TCMs) in both Dph1 and Dph2 subunits are critical for Fe-S cluster binding and structural integrity; mutagenesis of these cysteines (individually or in combination) in Dph1 reduces or eliminates diphthamide biosynthesis in vivo and leads to enhanced protein instability of the subunits.","method":"Site-directed mutagenesis, in vivo diphthamide assay, cycloheximide chase (protein stability assay)","journal":"Biomolecules","confidence":"Medium","confidence_rationale":"Tier 1-2 — mutagenesis combined with functional and protein stability assays","pmids":["38672486"],"is_preprint":false},{"year":2018,"finding":"OVCA1/DPH1 protein is degraded via the ubiquitin-proteasome pathway; it forms a poly-ubiquitinated complex (shown by co-immunoprecipitation), its degradation is inhibited by proteasome inhibitor MG132, and its half-life is less than 2 hours as measured by cycloheximide chase.","method":"Co-immunoprecipitation, proteasome inhibitor (MG132) treatment, cycloheximide chase","journal":"Oncology letters","confidence":"Medium","confidence_rationale":"Tier 3 — co-IP plus proteasome inhibitor, single lab but multiple orthogonal approaches","pmids":["30675298"],"is_preprint":false},{"year":2011,"finding":"Overexpression of OVCA1 in A2780 ovarian cancer cells inhibits proliferation with G1 arrest via downregulation of cyclin D1 and upregulation of p16, but not through NF-κB.","method":"Transfection/overexpression, Western blot, cell cycle analysis (FACS)","journal":"Molecular and cellular biochemistry","confidence":"Low","confidence_rationale":"Tier 3 — single lab, overexpression with pathway inference, no direct mechanistic link between DPH1 diphthamide function and p16/cyclin D1","pmids":["21487939"],"is_preprint":false},{"year":2023,"finding":"Ten DPH1 missense variants (G113R, A114T, H132P, H132R, S136R, C137F, L138P, Y152C, S221P, H240R) showed reduced functionality in complementation assays in yeast and mammalian DPH1-knockout cells, identifying them as diphthamide deficiency-susceptibility alleles; some locate near the active enzyme center and may affect catalysis.","method":"Complementation assay in DPH1ko yeast and mammalian cells, diphthamide synthesis readout","journal":"Disease models & mechanisms","confidence":"Medium","confidence_rationale":"Tier 2 — systematic variant analysis in two model systems with defined functional readout","pmids":["37675463"],"is_preprint":false}],"current_model":"DPH1 (OVCA1) forms a [4Fe-4S]-containing radical SAM heterodimer with DPH2 that catalyzes the first step of diphthamide biosynthesis on EF-2 — transferring the 3-amino-3-carboxypropyl group from SAM to a conserved histidine — with the Dph1 cluster playing the catalytic radical SAM role, the Dph2 cluster facilitating electron delivery, and Dph3 serving as both an electron donor and an iron donor to maintain the functional [4Fe-4S] cluster; loss of this diphthamide modification causes translational fidelity defects, confers diphtheria toxin resistance, and underlies the developmental and craniofacial defects of DPH1 syndrome."},"narrative":{"teleology":[{"year":1999,"claim":"The initial observation that OVCA1/DPH1 overexpression suppresses proliferation via G1 arrest and cyclin D1 degradation established it as a candidate growth-regulatory gene, though the molecular mechanism was unclear.","evidence":"Stable transfection in ovarian cancer cells with FACS and cyclin D1 rescue","pmids":["10519411"],"confidence":"Medium","gaps":["No connection to diphthamide or EF-2 modification was established","Mechanism linking DPH1 to cyclin D1 turnover was not identified","Overexpression-only, no loss-of-function data"]},{"year":2004,"claim":"Mouse knockout studies established that DPH1 loss causes cell-autonomous proliferation defects rescuable by p53 deficiency, placing DPH1 upstream of or parallel to p53 in cell-cycle control, but the biochemical function remained unknown.","evidence":"Ovca1-null and Ovca1;p53 double-mutant mice, MEF proliferation assays","pmids":["14744934"],"confidence":"High","gaps":["Biochemical activity of DPH1 was still uncharacterized","Whether growth suppression reflects diphthamide deficiency or another function was unknown"]},{"year":2005,"claim":"Gene-trap mutagenesis in CHO cells demonstrated that DPH1 is required for diphthamide modification of EF-2, definitively placing it in the diphthamide biosynthetic pathway and explaining diphtheria toxin resistance upon DPH1 loss.","evidence":"Gene trap mutagenesis with diphtheria toxin and Pseudomonas exotoxin A resistance assays","pmids":["15637051"],"confidence":"High","gaps":["Whether DPH1 acts enzymatically or as a scaffold was unknown","The relationship between diphthamide loss and the proliferation/developmental phenotypes was not addressed"]},{"year":2014,"claim":"In vitro reconstitution revealed that the Dph1–Dph2 heterodimer is the radical SAM enzyme catalyzing the first step of diphthamide biosynthesis—ACP transfer from SAM to EF-2 histidine—with Dph3 serving as the electron donor to reduce the Fe-S cluster.","evidence":"In vitro reconstitution with purified yeast Dph1–Dph2, EPR spectroscopy","pmids":["24422557"],"confidence":"High","gaps":["Which subunit harbors the catalytic vs. electron-relay cluster was not resolved","The SAM-binding site had not been mapped"]},{"year":2014,"claim":"Conditional knockout in mice showed that DPH1-dependent diphthamide biosynthesis is specifically required in neural crest cells for craniofacial development, connecting the enzyme's biochemical function to developmental disease.","evidence":"Cre-lox conditional ablation in neural crest vs. mesoderm, DT-A resistance assay in vivo","pmids":["24895408"],"confidence":"High","gaps":["How diphthamide deficiency on EF-2 leads to neural crest-specific defects (translational target genes) is unknown","Whether partial loss of diphthamide modification produces milder phenotypes was not tested"]},{"year":2019,"claim":"Mutagenesis of the [4Fe-4S] cluster-binding cysteines in each subunit demonstrated that the heterodimer functions asymmetrically: the Dph1 cluster is the catalytic radical SAM center, while the Dph2 cluster facilitates electron relay from the Dph3/Cbr1/NADH system.","evidence":"Site-directed mutagenesis of Fe-S cysteines, EPR spectroscopy, in vitro reconstitution and in vivo complementation","pmids":["31463593"],"confidence":"High","gaps":["Structural basis for asymmetric function awaited high-resolution structure","The precise electron transfer pathway from Dph2 to Dph1 was not resolved"]},{"year":2019,"claim":"Functional analysis of patient-derived DPH1 missense variants confirmed that specific mutations compromise catalytic activity and correlate with reduced catalytic site dimensions in a homology model, linking genotype to enzyme dysfunction in DPH1 syndrome.","evidence":"DT ADP-ribosylation assay on seven patient variants, homology modeling and molecular dynamics","pmids":["30877278"],"confidence":"Medium","gaps":["No experimental crystal structure of human DPH1–DPH2 was available","Effect of variants on protein stability vs. catalytic rate was not distinguished"]},{"year":2021,"claim":"Beyond its electron-donor role, Dph3 was shown to donate iron to restore an air-degraded [3Fe-4S] cluster to a functional [4Fe-4S] state, revealing a dual iron-chaperone/electron-donor mechanism essential for aerobic diphthamide biosynthesis.","evidence":"In vitro reconstitution, EPR spectroscopy, iron quantification","pmids":["34154323"],"confidence":"High","gaps":["Whether other iron chaperones can substitute for Dph3 in vivo is unknown","The mechanism of iron transfer from Dph3 to the cluster is not structurally resolved"]},{"year":2023,"claim":"Mutagenesis of the predicted SAM-binding pocket specific to Dph1 identified residues essential for SAM cleavage and ACP radical formation, pinpointing the active site within the heterodimer.","evidence":"Site-directed mutagenesis of SAM-pocket residues, in vivo diphthamide assay, structural modeling","pmids":["38002337"],"confidence":"Medium","gaps":["No co-crystal structure of DPH1 with SAM has been obtained","Kinetic parameters for individual active-site mutants were not measured"]},{"year":2024,"claim":"Tandem cysteine motifs in DPH1 were shown to be critical not only for Fe-S cluster binding but also for structural stability of the heterodimer, as their mutation causes enhanced protein degradation.","evidence":"Site-directed mutagenesis, in vivo diphthamide assay, cycloheximide chase","pmids":["38672486"],"confidence":"Medium","gaps":["Whether the ubiquitin-proteasome pathway mediates degradation of cluster-deficient DPH1 in this context was not tested","Relative contributions of cluster loss vs. misfolding to the functional defect are unclear"]},{"year":null,"claim":"A high-resolution experimental structure of the human DPH1–DPH2 heterodimer, the precise mechanism by which diphthamide deficiency causes neural crest-specific developmental defects (i.e., which mRNAs are mistranslated), and the E3 ligase controlling DPH1 turnover remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No experimental structure of the human DPH1–DPH2 complex exists","Translational targets affected by diphthamide loss in neural crest cells are unknown","The E3 ubiquitin ligase responsible for DPH1 degradation has not been identified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016740","term_label":"transferase activity","supporting_discovery_ids":[0,1,11]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,1]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,1,3,7]}],"complexes":["DPH1-DPH2 heterodimer"],"partners":["DPH2","DPH3","EEF2"],"other_free_text":[]},"mechanistic_narrative":"DPH1 is the catalytic subunit of a radical S-adenosylmethionine (SAM) enzyme that initiates diphthamide biosynthesis on elongation factor 2 (EF-2), a unique post-translational modification essential for translational fidelity, sensitivity to diphtheria toxin, and normal development. DPH1 forms an obligate heterodimer with DPH2, in which the DPH1-bound [4Fe-4S] cluster serves the catalytic radical SAM role—cleaving SAM to generate the 3-amino-3-carboxypropyl radical that forms a C–C bond with a conserved histidine on EF-2—while the DPH2 cluster relays electrons from the Dph3/Cbr1/NADH donor system [PMID:24422557, PMID:31463593]. Dph3 additionally donates iron to convert an air-degraded [3Fe-4S] cluster back to a functional [4Fe-4S] state, enabling aerobic activity [PMID:34154323]. Tandem cysteine motifs and a SAM-binding pocket in DPH1 are critical for cluster stability, SAM cleavage, and diphthamide synthesis [PMID:38672486, PMID:38002337], and loss-of-function variants in DPH1 cause DPH1 syndrome, a developmental disorder featuring craniofacial defects attributable to impaired diphthamide modification in neural crest cells [PMID:24895408, PMID:30877278]."},"prefetch_data":{"uniprot":{"accession":"Q9BZG8","full_name":"2-(3-amino-3-carboxypropyl)histidine synthase subunit 1","aliases":["Diphthamide biosynthesis protein 1","Diphtheria toxin resistance protein 1","Ovarian cancer-associated gene 1 protein","S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 1"],"length_aa":438,"mass_kda":48.1,"function":"Catalyzes the first step of diphthamide biosynthesis, a post-translational modification of histidine which occurs in elongation factor 2 (PubMed:30877278). DPH1 and DPH2 transfer a 3-amino-3-carboxypropyl (ACP) group from S-adenosyl-L-methionine (SAM) to a histidine residue, the reaction is assisted by a reduction system comprising DPH3 and a NADH-dependent reductase (By similarity). Acts as a tumor suppressor (PubMed:10519411)","subcellular_location":"Nucleus; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q9BZG8/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DPH1","classification":"Not Classified","n_dependent_lines":379,"n_total_lines":1208,"dependency_fraction":0.31374172185430466},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"DPH2","stoichiometry":10.0}],"url":"https://opencell.sf.czbiohub.org/search/DPH1","total_profiled":1310},"omim":[{"mim_id":"618391","title":"DIPHTHAMIDE BIOSYNTHESIS PROTEIN 6; DPH6","url":"https://www.omim.org/entry/618391"},{"mim_id":"616901","title":"DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FACIAL FEATURES, AND SPARSE HAIR 1; DEDSSH1","url":"https://www.omim.org/entry/616901"},{"mim_id":"611075","title":"DIPHTHAMIDE BIOSYNTHESIS PROTEIN 5; DPH5","url":"https://www.omim.org/entry/611075"},{"mim_id":"607896","title":"OVCA2 SERINE HYDROLASE DOMAIN-CONTAINING PROTEIN; OVCA2","url":"https://www.omim.org/entry/607896"},{"mim_id":"603527","title":"DIPHTHAMIDE BIOSYNTHESIS PROTEIN 1; DPH1","url":"https://www.omim.org/entry/603527"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Cell Junctions","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/DPH1"},"hgnc":{"alias_symbol":["OVCA1"],"prev_symbol":["DPH2L","DPH2L1"]},"alphafold":{"accession":"Q9BZG8","domains":[{"cath_id":"3.40.50.11840","chopping":"40-158","consensus_level":"high","plddt":93.7162,"start":40,"end":158},{"cath_id":"3.40.50.11850","chopping":"162-267","consensus_level":"high","plddt":97.3578,"start":162,"end":267},{"cath_id":"3.40.50.11860","chopping":"271-373","consensus_level":"high","plddt":97.4571,"start":271,"end":373}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BZG8","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BZG8-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BZG8-F1-predicted_aligned_error_v6.png","plddt_mean":86.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DPH1","jax_strain_url":"https://www.jax.org/strain/search?query=DPH1"},"sequence":{"accession":"Q9BZG8","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9BZG8.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9BZG8/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BZG8"}},"corpus_meta":[{"pmid":"14744934","id":"PMC_14744934","title":"Ovca1 regulates cell proliferation, embryonic development, and tumorigenesis.","date":"2004","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/14744934","citation_count":93,"is_preprint":false},{"pmid":"24422557","id":"PMC_24422557","title":"Dph3 is an electron donor for Dph1-Dph2 in the first step of eukaryotic diphthamide biosynthesis.","date":"2014","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/24422557","citation_count":58,"is_preprint":false},{"pmid":"10519411","id":"PMC_10519411","title":"Expression of OVCA1, a candidate tumor suppressor, is reduced in tumors and inhibits growth of ovarian cancer cells.","date":"1999","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/10519411","citation_count":53,"is_preprint":false},{"pmid":"23468660","id":"PMC_23468660","title":"The amidation step of diphthamide biosynthesis in yeast requires DPH6, a gene identified through mining the DPH1-DPH5 interaction network.","date":"2013","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23468660","citation_count":51,"is_preprint":false},{"pmid":"16232783","id":"PMC_16232783","title":"Isolation and characterization of a tetrachloroethylene dechlorinating bacterium, Clostridium bifermentans DPH-1.","date":"2000","source":"Journal of bioscience and bioengineering","url":"https://pubmed.ncbi.nlm.nih.gov/16232783","citation_count":47,"is_preprint":false},{"pmid":"11013075","id":"PMC_11013075","title":"Identification and structural analysis of human RBM8A and RBM8B: two highly conserved RNA-binding motif proteins that interact with OVCA1, a candidate tumor suppressor.","date":"2000","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/11013075","citation_count":44,"is_preprint":false},{"pmid":"24895408","id":"PMC_24895408","title":"Role of OVCA1/DPH1 in craniofacial abnormalities of Miller-Dieker syndrome.","date":"2014","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24895408","citation_count":37,"is_preprint":false},{"pmid":"26220823","id":"PMC_26220823","title":"Matching two independent cohorts validates DPH1 as a gene responsible for autosomal recessive intellectual disability with short stature, craniofacial, and ectodermal anomalies.","date":"2015","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/26220823","citation_count":36,"is_preprint":false},{"pmid":"11400736","id":"PMC_11400736","title":"Purification, cloning, and sequencing of an enzyme mediating the reductive dechlorination of tetrachloroethylene (PCE) from Clostridium bifermentans DPH-1.","date":"2001","source":"Canadian journal of microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/11400736","citation_count":25,"is_preprint":false},{"pmid":"15661533","id":"PMC_15661533","title":"OVCA1: tumor suppressor gene.","date":"2005","source":"Current opinion in genetics & development","url":"https://pubmed.ncbi.nlm.nih.gov/15661533","citation_count":24,"is_preprint":false},{"pmid":"15637051","id":"PMC_15637051","title":"Gene trap mutagenesis-based forward genetic approach reveals that the tumor suppressor OVCA1 is a component of the biosynthetic pathway of diphthamide on elongation factor 2.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15637051","citation_count":24,"is_preprint":false},{"pmid":"30877278","id":"PMC_30877278","title":"DPH1 syndrome: two novel variants and structural and functional analyses of seven missense variants identified in syndromic patients.","date":"2019","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/30877278","citation_count":20,"is_preprint":false},{"pmid":"11333032","id":"PMC_11333032","title":"In vitro dehalogenation of tetrachloroethylene (PCE) by cell-free extracts of Clostridium bifermentans DPH-1.","date":"2001","source":"Bioresource technology","url":"https://pubmed.ncbi.nlm.nih.gov/11333032","citation_count":18,"is_preprint":false},{"pmid":"24070652","id":"PMC_24070652","title":"Methylation of the DPH1 promoter causes immunotoxin resistance in acute lymphoblastic leukemia cell line KOPN-8.","date":"2013","source":"Leukemia research","url":"https://pubmed.ncbi.nlm.nih.gov/24070652","citation_count":17,"is_preprint":false},{"pmid":"29410513","id":"PMC_29410513","title":"A novel homozygous DPH1 mutation causes intellectual disability and unique craniofacial features.","date":"2018","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29410513","citation_count":15,"is_preprint":false},{"pmid":"11527402","id":"PMC_11527402","title":"Cloning, structure, and expression of the mouse Ovca1 gene.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11527402","citation_count":15,"is_preprint":false},{"pmid":"28245596","id":"PMC_28245596","title":"Influence of DPH1 and DPH5 Protein Variants on the Synthesis of Diphthamide, the Target of ADPRibosylating Toxins.","date":"2017","source":"Toxins","url":"https://pubmed.ncbi.nlm.nih.gov/28245596","citation_count":14,"is_preprint":false},{"pmid":"31463593","id":"PMC_31463593","title":"The asymmetric function of Dph1-Dph2 heterodimer in diphthamide biosynthesis.","date":"2019","source":"Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31463593","citation_count":14,"is_preprint":false},{"pmid":"29362492","id":"PMC_29362492","title":"Novel compound heterozygous DPH1 mutations in a patient with the unique clinical features of airway obstruction and external genital abnormalities.","date":"2018","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29362492","citation_count":12,"is_preprint":false},{"pmid":"21487939","id":"PMC_21487939","title":"OVCA1 inhibits the proliferation of epithelial ovarian cancer cells by decreasing cyclin D1 and increasing p16.","date":"2011","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21487939","citation_count":12,"is_preprint":false},{"pmid":"34154323","id":"PMC_34154323","title":"Dph3 Enables Aerobic Diphthamide Biosynthesis by Donating One Iron Atom to Transform a [3Fe-4S] to a [4Fe-4S] Cluster in Dph1-Dph2.","date":"2021","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/34154323","citation_count":11,"is_preprint":false},{"pmid":"37675463","id":"PMC_37675463","title":"DPH1 and DPH2 variants that confer susceptibility to diphthamide deficiency syndrome in human cells and yeast models.","date":"2023","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/37675463","citation_count":7,"is_preprint":false},{"pmid":"18181179","id":"PMC_18181179","title":"Ovca1, a candidate gene of the genetic modifier of Tp53, Mop2, affects mouse embryonic lethality.","date":"2008","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/18181179","citation_count":7,"is_preprint":false},{"pmid":"38002337","id":"PMC_38002337","title":"DPH1 Gene Mutations Identify a Candidate SAM Pocket in Radical Enzyme Dph1•Dph2 for Diphthamide Synthesis on EF2.","date":"2023","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/38002337","citation_count":4,"is_preprint":false},{"pmid":"30675298","id":"PMC_30675298","title":"The tumor suppressor OVCA1 is a short half-life protein degraded by the ubiquitin-proteasome pathway.","date":"2018","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/30675298","citation_count":2,"is_preprint":false},{"pmid":"34990869","id":"PMC_34990869","title":"The functional variant in promoter of OVCA1 was associated with the risk of gastric cancer in the northeast Chinese Han population.","date":"2021","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/34990869","citation_count":2,"is_preprint":false},{"pmid":"40200557","id":"PMC_40200557","title":"Diphthamide formation in Arabidopsis requires DPH1-interacting DPH2 for light and oxidative stress resistance.","date":"2025","source":"Plant physiology","url":"https://pubmed.ncbi.nlm.nih.gov/40200557","citation_count":1,"is_preprint":false},{"pmid":"39166428","id":"PMC_39166428","title":"Recessive loss-of-function variants in DPH1 identified as the molecular cause in a sibling pair previously diagnosed with Fine-Lubinsky syndrome.","date":"2024","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/39166428","citation_count":1,"is_preprint":false},{"pmid":"41236573","id":"PMC_41236573","title":"Establishment and characterization of a novel imatinib-resistant dermatofibrosarcoma protuberans cell line, DFSP-DPH1.","date":"2025","source":"Human cell","url":"https://pubmed.ncbi.nlm.nih.gov/41236573","citation_count":0,"is_preprint":false},{"pmid":"38672486","id":"PMC_38672486","title":"Functional Integrity of Radical SAM Enzyme Dph1•Dph2 Requires Non-Canonical Cofactor Motifs with Tandem Cysteines.","date":"2024","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/38672486","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":15507,"output_tokens":3805,"usd":0.051798},"stage2":{"model":"claude-opus-4-6","input_tokens":7238,"output_tokens":2698,"usd":0.15546},"total_usd":0.207258,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2014,\n      \"finding\": \"Yeast Dph1 and Dph2 form a heterodimeric complex (Dph1-Dph2) that is equivalent to the archaeal PhDph2 homodimer and is sufficient to catalyze the first step of diphthamide biosynthesis in vitro — the transfer of the 3-amino-3-carboxypropyl (ACP) group from SAM to the histidine residue of EF2, forming a C-C bond. Dph3 (KTI11), a CSL-type zinc finger protein that binds iron, serves as an electron donor in its reduced state to reduce the Fe-S cluster in Dph1-Dph2.\",\n      \"method\": \"In vitro reconstitution, EPR spectroscopy\",\n      \"journal\": \"Journal of the American Chemical Society\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with biochemical and spectroscopic validation\",\n      \"pmids\": [\"24422557\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The Dph1-Dph2 heterodimer functions asymmetrically: the [4Fe-4S] cluster-binding cysteine residues in each subunit are required for diphthamide biosynthesis in vivo, with the Dph1 cluster serving a catalytic (radical SAM) role while the Dph2 cluster facilitates reduction of the Dph1 cluster by the physiological electron donor system Dph3/Cbr1/NADH.\",\n      \"method\": \"In vitro reconstitution with site-directed mutagenesis of Fe-S cluster cysteine residues, EPR spectroscopy, in vivo complementation assays\",\n      \"journal\": \"Journal of biological inorganic chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis combined with in vitro reconstitution and EPR, defining asymmetric roles of each subunit\",\n      \"pmids\": [\"31463593\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Dph3 donates one iron atom to convert an air-degraded [3Fe-4S] cluster in Dph1-Dph2 into a functional [4Fe-4S] cluster, enabling aerobic diphthamide biosynthesis in vivo.\",\n      \"method\": \"In vitro reconstitution, EPR spectroscopy, biochemical iron quantification\",\n      \"journal\": \"Journal of the American Chemical Society\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct biochemical reconstitution showing iron transfer, spectroscopically validated\",\n      \"pmids\": [\"34154323\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"DPH1/OVCA1 is a component of the diphthamide biosynthetic pathway in mammalian cells; disruption of the Ovca1 gene by gene trap mutagenesis in CHO cells confers resistance to diphtheria toxin and Pseudomonas exotoxin A, demonstrating that DPH1 is required for diphthamide modification of EF-2.\",\n      \"method\": \"Gene trap mutagenesis, diphtheria toxin resistance assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean loss-of-function with defined molecular phenotype (diphthamide loss), replicated by later studies\",\n      \"pmids\": [\"15637051\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Loss of Ovca1 (DPH1) in mice causes cell-autonomous proliferation defects in MEFs; p53 deficiency rescues these proliferation defects and partially rescues embryonic phenotypes, placing Ovca1 genetically upstream of or in a parallel pathway to p53 for cell cycle progression.\",\n      \"method\": \"Mouse knockout, MEF proliferation assays, genetic epistasis (double mutant Ovca1;p53)\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis with p53 via double-mutant rescue, multiple phenotypic readouts in vivo\",\n      \"pmids\": [\"14744934\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Overexpression of OVCA1 in ovarian cancer A2780 cells causes a 50-60% reduction in colony formation, reduced proliferation, G1 cell cycle arrest, decreased cyclin D1 levels due to accelerated degradation, and overexpression of cyclin D1 overrides OVCA1-mediated growth suppression.\",\n      \"method\": \"Stable transfection, colony formation assay, cell cycle FACS, cyclin D1 overexpression rescue\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss/gain of function with defined cell cycle phenotype and cyclin D1 rescue, single lab\",\n      \"pmids\": [\"10519411\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"OVCA1 physically interacts with RBM8A and RBM8B (RNA-binding motif proteins), identified by yeast two-hybrid screening.\",\n      \"method\": \"Yeast two-hybrid\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single yeast two-hybrid interaction, no orthogonal validation\",\n      \"pmids\": [\"11013075\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"OVCA1/DPH1-dependent diphthamide biosynthesis is required specifically in neural crest cells for craniofacial development (cleft palate, shortened mandible phenotypes); conditional ablation of Ovca1 in neural crest cells but not cranial paraxial mesoderm reproduces these defects, and Ovca1-null mice are resistant to diphtheria toxin subunit A-mediated neural crest cell ablation, confirming the link between DPH1 function and diphthamide on EF-2.\",\n      \"method\": \"Conditional knockout (Cre-lox in neural crest vs. mesoderm), diphtheria toxin subunit A resistance assay, transgenic rescue\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific conditional KO with defined craniofacial phenotype and molecular rescue, multiple orthogonal approaches\",\n      \"pmids\": [\"24895408\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Methylation of the CpG island in the DPH1 promoter causes transcriptional silencing of DPH1, resulting in low DPH1 RNA/protein, failure to produce diphthamide on EF-2, and resistance to the anti-CD22 immunotoxin HA22 (moxetumomab pasudotox) in the ALL cell line KOPN-8; 5-azacytidine prevents methylation and restores sensitivity.\",\n      \"method\": \"Bisulfite sequencing/methylation analysis, RT-PCR, Western blot, immunotoxin resistance assay, 5-azacytidine treatment\",\n      \"journal\": \"Leukemia research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epigenetic writer identified (methylation), functional consequence on DPH1 expression and immunotoxin sensitivity demonstrated in cell line\",\n      \"pmids\": [\"24070652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Functional assays in DPH1-knockout cells demonstrated that the N-terminal region and C-terminal region of DPH1 are both required for diphthamide synthesis: N-terminal truncations (L96fs*) and splice isoforms lacking 80 or 140 N-terminal amino acids are inactive, while the frameshift variant R312fs* (lacking most of the C-terminus) retains residual activity; specific missense variants S221P reduce activity while R27W and S56F retain full activity.\",\n      \"method\": \"Complementation assay in DPH1-knockout cells, diphtheria toxin ADP-ribosylation assay\",\n      \"journal\": \"Toxins\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — systematic mutagenesis with functional diphthamide readout in KO cells, single lab\",\n      \"pmids\": [\"28245596\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Functional analysis of seven DPH1 missense variants from DPH1 syndrome patients using a diphtheria toxin ADP-ribosylation assay showed that five variants [p.(Leu234Pro), p.(Ala411Argfs*91), p.(Leu164Pro), p.(Leu125Pro), p.(Tyr112Cys)] compromise DPH1 function; homology modeling of the human DPH1-DPH2 heterodimer showed that loss of activity correlates with reduced opening and size of the catalytic site.\",\n      \"method\": \"Diphtheria toxin ADP-ribosylation assay, homology modeling, molecular dynamics simulations\",\n      \"journal\": \"European journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro functional assay combined with structural modeling, multiple variants tested\",\n      \"pmids\": [\"30877278\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Site-directed mutagenesis of a predicted SAM-binding pocket in Dph1 (near the FeS cluster domain, conserved in eukaryotic Dph1 but not Dph2) abolishes diphthamide synthesis in vivo, identifying specific residues near the methionine moiety of SAM as essential for SAM cleavage and ACP radical formation by the Dph1•Dph2 radical SAM enzyme.\",\n      \"method\": \"Site-directed mutagenesis, in vivo diphthamide assay, structural modeling\",\n      \"journal\": \"Biomolecules\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — mutagenesis of active site residues with in vivo functional diphthamide readout\",\n      \"pmids\": [\"38002337\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Tandem cysteine motifs (TCMs) in both Dph1 and Dph2 subunits are critical for Fe-S cluster binding and structural integrity; mutagenesis of these cysteines (individually or in combination) in Dph1 reduces or eliminates diphthamide biosynthesis in vivo and leads to enhanced protein instability of the subunits.\",\n      \"method\": \"Site-directed mutagenesis, in vivo diphthamide assay, cycloheximide chase (protein stability assay)\",\n      \"journal\": \"Biomolecules\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — mutagenesis combined with functional and protein stability assays\",\n      \"pmids\": [\"38672486\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"OVCA1/DPH1 protein is degraded via the ubiquitin-proteasome pathway; it forms a poly-ubiquitinated complex (shown by co-immunoprecipitation), its degradation is inhibited by proteasome inhibitor MG132, and its half-life is less than 2 hours as measured by cycloheximide chase.\",\n      \"method\": \"Co-immunoprecipitation, proteasome inhibitor (MG132) treatment, cycloheximide chase\",\n      \"journal\": \"Oncology letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — co-IP plus proteasome inhibitor, single lab but multiple orthogonal approaches\",\n      \"pmids\": [\"30675298\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Overexpression of OVCA1 in A2780 ovarian cancer cells inhibits proliferation with G1 arrest via downregulation of cyclin D1 and upregulation of p16, but not through NF-κB.\",\n      \"method\": \"Transfection/overexpression, Western blot, cell cycle analysis (FACS)\",\n      \"journal\": \"Molecular and cellular biochemistry\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, overexpression with pathway inference, no direct mechanistic link between DPH1 diphthamide function and p16/cyclin D1\",\n      \"pmids\": [\"21487939\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Ten DPH1 missense variants (G113R, A114T, H132P, H132R, S136R, C137F, L138P, Y152C, S221P, H240R) showed reduced functionality in complementation assays in yeast and mammalian DPH1-knockout cells, identifying them as diphthamide deficiency-susceptibility alleles; some locate near the active enzyme center and may affect catalysis.\",\n      \"method\": \"Complementation assay in DPH1ko yeast and mammalian cells, diphthamide synthesis readout\",\n      \"journal\": \"Disease models & mechanisms\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — systematic variant analysis in two model systems with defined functional readout\",\n      \"pmids\": [\"37675463\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DPH1 (OVCA1) forms a [4Fe-4S]-containing radical SAM heterodimer with DPH2 that catalyzes the first step of diphthamide biosynthesis on EF-2 — transferring the 3-amino-3-carboxypropyl group from SAM to a conserved histidine — with the Dph1 cluster playing the catalytic radical SAM role, the Dph2 cluster facilitating electron delivery, and Dph3 serving as both an electron donor and an iron donor to maintain the functional [4Fe-4S] cluster; loss of this diphthamide modification causes translational fidelity defects, confers diphtheria toxin resistance, and underlies the developmental and craniofacial defects of DPH1 syndrome.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"DPH1 is the catalytic subunit of a radical S-adenosylmethionine (SAM) enzyme that initiates diphthamide biosynthesis on elongation factor 2 (EF-2), a unique post-translational modification essential for translational fidelity, sensitivity to diphtheria toxin, and normal development. DPH1 forms an obligate heterodimer with DPH2, in which the DPH1-bound [4Fe-4S] cluster serves the catalytic radical SAM role—cleaving SAM to generate the 3-amino-3-carboxypropyl radical that forms a C–C bond with a conserved histidine on EF-2—while the DPH2 cluster relays electrons from the Dph3/Cbr1/NADH donor system [PMID:24422557, PMID:31463593]. Dph3 additionally donates iron to convert an air-degraded [3Fe-4S] cluster back to a functional [4Fe-4S] state, enabling aerobic activity [PMID:34154323]. Tandem cysteine motifs and a SAM-binding pocket in DPH1 are critical for cluster stability, SAM cleavage, and diphthamide synthesis [PMID:38672486, PMID:38002337], and loss-of-function variants in DPH1 cause DPH1 syndrome, a developmental disorder featuring craniofacial defects attributable to impaired diphthamide modification in neural crest cells [PMID:24895408, PMID:30877278].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"The initial observation that OVCA1/DPH1 overexpression suppresses proliferation via G1 arrest and cyclin D1 degradation established it as a candidate growth-regulatory gene, though the molecular mechanism was unclear.\",\n      \"evidence\": \"Stable transfection in ovarian cancer cells with FACS and cyclin D1 rescue\",\n      \"pmids\": [\"10519411\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No connection to diphthamide or EF-2 modification was established\",\n        \"Mechanism linking DPH1 to cyclin D1 turnover was not identified\",\n        \"Overexpression-only, no loss-of-function data\"\n      ]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Mouse knockout studies established that DPH1 loss causes cell-autonomous proliferation defects rescuable by p53 deficiency, placing DPH1 upstream of or parallel to p53 in cell-cycle control, but the biochemical function remained unknown.\",\n      \"evidence\": \"Ovca1-null and Ovca1;p53 double-mutant mice, MEF proliferation assays\",\n      \"pmids\": [\"14744934\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Biochemical activity of DPH1 was still uncharacterized\",\n        \"Whether growth suppression reflects diphthamide deficiency or another function was unknown\"\n      ]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Gene-trap mutagenesis in CHO cells demonstrated that DPH1 is required for diphthamide modification of EF-2, definitively placing it in the diphthamide biosynthetic pathway and explaining diphtheria toxin resistance upon DPH1 loss.\",\n      \"evidence\": \"Gene trap mutagenesis with diphtheria toxin and Pseudomonas exotoxin A resistance assays\",\n      \"pmids\": [\"15637051\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether DPH1 acts enzymatically or as a scaffold was unknown\",\n        \"The relationship between diphthamide loss and the proliferation/developmental phenotypes was not addressed\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"In vitro reconstitution revealed that the Dph1–Dph2 heterodimer is the radical SAM enzyme catalyzing the first step of diphthamide biosynthesis—ACP transfer from SAM to EF-2 histidine—with Dph3 serving as the electron donor to reduce the Fe-S cluster.\",\n      \"evidence\": \"In vitro reconstitution with purified yeast Dph1–Dph2, EPR spectroscopy\",\n      \"pmids\": [\"24422557\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Which subunit harbors the catalytic vs. electron-relay cluster was not resolved\",\n        \"The SAM-binding site had not been mapped\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Conditional knockout in mice showed that DPH1-dependent diphthamide biosynthesis is specifically required in neural crest cells for craniofacial development, connecting the enzyme's biochemical function to developmental disease.\",\n      \"evidence\": \"Cre-lox conditional ablation in neural crest vs. mesoderm, DT-A resistance assay in vivo\",\n      \"pmids\": [\"24895408\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"How diphthamide deficiency on EF-2 leads to neural crest-specific defects (translational target genes) is unknown\",\n        \"Whether partial loss of diphthamide modification produces milder phenotypes was not tested\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Mutagenesis of the [4Fe-4S] cluster-binding cysteines in each subunit demonstrated that the heterodimer functions asymmetrically: the Dph1 cluster is the catalytic radical SAM center, while the Dph2 cluster facilitates electron relay from the Dph3/Cbr1/NADH system.\",\n      \"evidence\": \"Site-directed mutagenesis of Fe-S cysteines, EPR spectroscopy, in vitro reconstitution and in vivo complementation\",\n      \"pmids\": [\"31463593\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis for asymmetric function awaited high-resolution structure\",\n        \"The precise electron transfer pathway from Dph2 to Dph1 was not resolved\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Functional analysis of patient-derived DPH1 missense variants confirmed that specific mutations compromise catalytic activity and correlate with reduced catalytic site dimensions in a homology model, linking genotype to enzyme dysfunction in DPH1 syndrome.\",\n      \"evidence\": \"DT ADP-ribosylation assay on seven patient variants, homology modeling and molecular dynamics\",\n      \"pmids\": [\"30877278\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No experimental crystal structure of human DPH1–DPH2 was available\",\n        \"Effect of variants on protein stability vs. catalytic rate was not distinguished\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Beyond its electron-donor role, Dph3 was shown to donate iron to restore an air-degraded [3Fe-4S] cluster to a functional [4Fe-4S] state, revealing a dual iron-chaperone/electron-donor mechanism essential for aerobic diphthamide biosynthesis.\",\n      \"evidence\": \"In vitro reconstitution, EPR spectroscopy, iron quantification\",\n      \"pmids\": [\"34154323\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether other iron chaperones can substitute for Dph3 in vivo is unknown\",\n        \"The mechanism of iron transfer from Dph3 to the cluster is not structurally resolved\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Mutagenesis of the predicted SAM-binding pocket specific to Dph1 identified residues essential for SAM cleavage and ACP radical formation, pinpointing the active site within the heterodimer.\",\n      \"evidence\": \"Site-directed mutagenesis of SAM-pocket residues, in vivo diphthamide assay, structural modeling\",\n      \"pmids\": [\"38002337\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No co-crystal structure of DPH1 with SAM has been obtained\",\n        \"Kinetic parameters for individual active-site mutants were not measured\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Tandem cysteine motifs in DPH1 were shown to be critical not only for Fe-S cluster binding but also for structural stability of the heterodimer, as their mutation causes enhanced protein degradation.\",\n      \"evidence\": \"Site-directed mutagenesis, in vivo diphthamide assay, cycloheximide chase\",\n      \"pmids\": [\"38672486\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether the ubiquitin-proteasome pathway mediates degradation of cluster-deficient DPH1 in this context was not tested\",\n        \"Relative contributions of cluster loss vs. misfolding to the functional defect are unclear\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A high-resolution experimental structure of the human DPH1–DPH2 heterodimer, the precise mechanism by which diphthamide deficiency causes neural crest-specific developmental defects (i.e., which mRNAs are mistranslated), and the E3 ligase controlling DPH1 turnover remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No experimental structure of the human DPH1–DPH2 complex exists\",\n        \"Translational targets affected by diphthamide loss in neural crest cells are unknown\",\n        \"The E3 ubiquitin ligase responsible for DPH1 degradation has not been identified\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\n        \"term_id\": \"GO:0016740\",\n        \"supporting_discovery_ids\": [0, 1, 11]\n      }\n    ],\n    \"localization\": [\n      {\n        \"term_id\": \"GO:0005829\",\n        \"supporting_discovery_ids\": [0, 1]\n      }\n    ],\n    \"pathway\": [\n      {\n        \"term_id\": \"R-HSA-392499\",\n        \"supporting_discovery_ids\": [0, 1, 3, 7]\n      }\n    ],\n    \"complexes\": [\n      \"DPH1-DPH2 heterodimer\"\n    ],\n    \"partners\": [\n      \"DPH2\",\n      \"DPH3\",\n      \"EEF2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}